ggpoker中文 and STI Biotechnologie European Market Agreement for Microbe-based Soil/Rhizosphere Enhancer
Something went wrong. Please try again later...
INDIANAPOLIS, USA; Saint Etienne en Cogles, FRANCE, October 19, 2022 鈥 ggpoker中文 Agriscience and STI Biotechnologie, an expert in microbiological technologies, announced today a multi-year agreement for the distribution of two Lactobacillus strains for plant stimulations. The agreement includes all countries on the European continent.
Through the agreement, STI Biotechnologie is providing an exclusive distribution license to ggpoker中文 for a dedicated formulation of their proprietary Lactobacillus Farciminis CNCM-I-3699 and Rhamnosus CNCM-I-3698, which work with the plant to improve soil conditions and rhizosphere. The technologies work in field and greenhouse conditions, helping improve soil life and nutrient interactions.
ggpoker中文 will leverage its wide distribution network and market reach to make the product, sold under the brand name Utrisha鈩 Rhizo biostimulant, available for all crops, with a primary focus on vegetables and potatoes.
鈥済gpoker中文 Agriscience continues to bring new and innovative solutions to market by offering natural-origin products that contribute to plant resilience that also complement our conventional crop protection solutions,鈥 Priscila Vansetti, Vice President, Biologicals and Business Development, Crop Protection Business Unit, ggpoker中文 Agriscience. 鈥淲e鈥檙e excited to work with STI Biotechnologie to scale up and maximize sustainable options that help farmers meet changing environmental conditions while keeping their crops productive and healthy.鈥
This collaboration represents another step forward for ggpoker中文鈥檚 expanding global Biologicals portfolio, which is dedicated to developing biostimulants and biocontrol products with proven, predictable performance. Utrisha鈩 Rhizo, a technology powered by STI Biotechnologie, will provide value through integrated nutrition management efficiency and enhancing yield potential and sustainability, in line with ggpoker中文鈥檚 commitment to sustainable innovation.
鈥淭his partnership perfectly fits with our aim to provide natural biological solutions to increase crops development and resilience鈥 says Christophe Tanguy, Director of Operations at STI Biotechnologie. 鈥淭his agreement with a multinational company such as ggpoker中文 will accelerate the deployment of our soil health Biostimulant and fulfill farmers growing demand for natural solutions increasing crop resilience and soil health,鈥 says Renaud Domitile, CEO.
Terms of the agreement were not disclosed.
About ggpoker中文
ggpoker中文, Inc. (NYSE: CTVA) is a publicly traded, global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world鈥檚 most pressing agriculture challenges. ggpoker中文 generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the Company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.Follow ggpoker中文 Agriscience on , , , and .
About STI Biotechnologie
STI Biotechnologie is a French company, founded in 2007, producing solutions based on Lactic Bacteria historically developped in the animal feed business and agri-environmental uses. Since 2020, STI Biotechnologie is part of the IDENA group, specialized in natural feed solutions.
STI Biotechnologie owns two Lactobacillus Strains (Farciminis CNCM-I-3699 and Rhamnosus CNCM-I-3698) and has been expamding agronomic applications and registrations obtained in France, Belgium and Portugal. 鈥淭his microbial solution improves crop performances鈥.
More information can be found at
Follow STI Biotechnologie on .
# # #
Cautionary Statement About Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like 鈥減lans,鈥 鈥渆xpects,鈥 鈥渨ill,鈥 鈥渁nticipates,鈥 鈥渂elieves,鈥 鈥渋ntends,鈥 鈥減rojects,鈥 鈥渢argets,鈥 鈥渆stimates,鈥 "outlook," or other words of similar meaning. All statements that address expectations or projections about the future, including statements about completion of this transaction and ggpoker中文's financial results or outlook; strategy for growth; product development; regulatory approvals; market position; capital allocation strategy; liquidity; environmental, social and governance ("ESG") targets and initiatives; and the anticipated benefits of acquisitions restructuring actions, or cost savings initiatives are forward-looking statements.
Forward-looking statements are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements and other estimates also involve risks and uncertainties, many of which are beyond ggpoker中文's control. While the list of factors presented below is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on ggpoker中文's business, results of operations and financial condition. Some of the important factors that could cause ggpoker中文's actual results to differ materially from those projected in any such forward-looking statements include: (i) failure to successfully develop and commercialize ggpoker中文's pipeline; (ii) failure to obtain or maintain the necessary regulatory approvals for some of ggpoker中文's products; (iii) effect of the degree of public understanding and acceptance or perceived public acceptance of ggpoker中文's biotechnology and other agricultural products; (iv) effect of changes in agricultural and related policies of governments and international organizations; (v) effect of competition and consolidation in ggpoker中文's industry; (vi) effect of competition from manufacturers of generic products; (vii) costs of complying with evolving regulatory requirements and the effect of actual or alleged violations of environmental laws or permit requirements; (viii) effect of climate change and unpredictable seasonal and weather factors; (ix) failure to comply with competition and antitrust laws; (x) competitor's establishment of an intermediary platform for distribution of ggpoker中文's products; (xi) impact of ggpoker中文's dependence on third parties with respect to certain of its raw materials or licenses and commercialization; (xii) effect of industrial espionage and other disruptions to ggpoker中文's supply chain, information technology or network systems; (xiii) effect of volatility in ggpoker中文's input costs; (xiv) failure to raise capital through the capital markets or short-term borrowings on terms acceptable to ggpoker中文; (xv) failure of ggpoker中文's customers to pay their debts to ggpoker中文, including customer financing programs; (xvi) increases in pension and other post-employment benefit plan funding obligations; (xvii) risks related to environmental litigation and the indemnification obligations of legacy EID liabilities in connection with the separation of ggpoker中文; (xviii) risks related to ggpoker中文's global operations; (xix) failure to effectively manage acquisitions, divestitures, alliances, restructurings, cost savings initiatives, and other portfolio actions; (xx) capital markets sentiment towards ESG matters (xxi) risks related to COVID-19; (xxii) ggpoker中文's ability to recruit and retain key personnel; (xxiii) ggpoker中文's intellectual property rights or defend against intellectual property claims asserted by others; (xxiv) effect of counterfeit products; (xxv) ggpoker中文's dependence on intellectual property cross-license agreements; (xxvi) other risks related to the Separation from DowDuPont; and (xxvii) risks related to the Russia and Ukraine military conflict.
Additionally, there may be other risks and uncertainties that ggpoker中文 is unable to currently identify or that ggpoker中文 does not currently expect to have a material impact on its business. Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of ggpoker中文鈥檚 management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. ggpoker中文 disclaims and does not undertake any obligation to update or revise any forward-looking statement, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the "Risk Factors" section of ggpoker中文鈥檚 Annual Report on Form 10-K, as modified by subsequent Quarterly Reports on Forms 10-Q and Current Reports on Form 8-K.
# # #
10/19/2022
鈩 庐 Trademarks of ggpoker中文 Agriscience and its affiliated companies.
Media Contacts:
ggpoker中文 Agriscience
J贸zsef M谩t茅 鈥 EMEA
+41 22 775 3670
jozsef.mate@corteva.com
STI Biotechnologie
Christophe Tanguy
c.tanguy@sti-biotechnologie.fr
+33 6 42 30 50 16